KENVUE INC
KVUENYSETrading Snapshot
- Day Range
- β
- 52-Week Range
- $14.02 β $20.13
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 1.92B
- Next Earnings
- 2026-10-30
Fundamentals Snapshot
- Annual Revenue
- $15.12B
- Last Q Revenue
- $3.96B
- P/E Ratio
- 22.5
- P/S Ratio
- 2.4x
- EPS (TTM)
- $0.86
- Dividend Yield
- 4.27%
- Dilution (1yr)
- β0.5%
KENVUE INC
KVUEAbout KENVUE INC
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates
News unavailable.